Allergan CEO says Botox maker's new depression drug could be an 'absolute game-changer'

Jim Cramer sits down with Allergan Chairman and CEO Brent Saunders after earnings to hear about the pharmaceutical giant's latest ventures.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.